TARPLIN, DOWNS & YOUNG, LLC for ABBVIE INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations H.R. 244 - Consolidated Appropriations Act of 2017 S.Con.Res. 25 - Senate budget resolution H.Res. 553 - House budget resolution H.J. Res. 123, H.R. 1370 - Continuing Resolution
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte. |
| MICHELLE P EASTON | Chief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy Tauzin |
| CHARLOTTE SPEARS IVANCIC | Legislative Counsel, Senator Jim DeMint; Health Counsel, Majority Leader Bill Frist; Counsel and Budget Analyst, House Budget Committee; Asst. to the Speaker for Policy, Speaker John Boehner |
| ELIZABETH T MURRAY | Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham |
| PAMELA SMITH | Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept of Justice; Spec Counsel, Ofc of Leg. Affairs, Dept of Justice; Counsel and LA, Senator Carol Moseley-Braun |
| JENNIFER B YOUNG | Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance |
Copyright/Patent/Trademark CPT
patent issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| CHARLOTTE SPEARS IVANCIC | — |
| ELIZABETH T MURRAY | — |
| PAMELA SMITH | — |
| JENNIFER B YOUNG | — |
Health Issues HCR
PL114-255 - 21st Century Cures, implementation H.R. 1231/S. 456 - RACE for Children Act H.R 1628 - American Health Care Act of 2017 S. 771 - Improving Access to Affordable Prescription Drugs Act S. 637 - Creating Transparency to Have Drug Rebates Unlocked Act of 2017 Stopping the Pharmaceutical Industry From Keeping Drugs Expensive Act of 2017 S. 469 - Affordable and Safe Prescription Drug Importation act H.R. 749 - Lower Drug Costs Through Competition Act H.R. 2430 - FDA Reauthorization Act of 2017 S. 1827 - KIDS Act of 2017 no specific bill - FDA implementation issues, 340B, biosimilars, prescription drug user fee reauthorization, non-interference, patient assistance
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| CHARLOTTE SPEARS IVANCIC | — |
| ELIZABETH T MURRAY | — |
| PAMELA SMITH | — |
| JENNIFER B YOUNG | — |
Medicare/Medicaid MMM
discount programs, hepatitis C, Sunshine, pipeline, biosimilars, Part B demonstration, Part D, Noninterference S. 251 - Protecting Medicare from Executive Action of 2017 S. 260/H.R. 849 - Protecting Seniors' Access to Medicare Act of 2017 H.J.Res. 51/S.J.Res. 16 - IPAB discontinuation S. 41 - Medicare Prescription Drug Price Negotiation Act of 2017 H.R. 3921 - Healthy Kids Act S. 1827 - KIDS Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHELLE P EASTON | — |
| CHARLOTTE SPEARS IVANCIC | — |
| ELIZABETH T MURRAY | — |
| PAMELA SMITH | — |
| JENNIFER B YOUNG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.